Policy Statements
The American Society of Hematology represents the interests of hematologists and their patients before Congress and the Executive branch, advocating for the best science and practice of hematology. When warranted, ASH issues policy statements on research, practice, training, or quality of care issues that are likely to have an impact on the field.
ASH Position on Sickle Cell Trait
ASH Position Listing "sickle cell crisis" or "sickle cell trait" as a cause of death on an autopsy report for an individual with sickle cell trait is medically inaccurate and without medical evidence of causation. Sickle cell trait occurs when an ind...
Read moreASH Policy Statement on Coverage of Fertility Treatment in Hematologic Care
Fertility preservation and management is a critical aspect of reproductive health care to safeguard an individual's ability to have children in the future. The primary goal of fertility preservation is to provide options for reproductive life plannin...
Read moreAccess to Hematology Care in an Age of Innovation
Access to Hematology Care in an Age of Innovation The American Society of Hematology (ASH) believes that all individuals should have access to and be able to afford high-quality, clinically appropriate care, including innovative therapeutics. Hema...
Read moreStatement on a Strong Blood Supply
The American Society of Hematology (ASH) represents over 18,000 physicians, scientists, and medical trainees committed to the study of blood and treatment of blood-related diseases. ASH members include clinicians who specialize in treating children a...
Read moreMaternal Rights Policy Statement
Maternal deaths have been increasing in the United States since 2000. According to the Centers for Disease Control and Prevention (CDC), the maternal mortality rate was 20.1 per 100,000 live births in the United States in 2019. The corresponding num...
Read moreStatement in Support of the Value of Scholarly Publishers
As a member of the Council of Medical Specialty Societies (CMSS) and an organization committed to promoting and supporting clinical and scientific research in hematology, the American Society of Hematology (ASH) supports the CMSS statement on the val...
Read moreASH Statement Addressing Diversity, Equity, and Inclusion in Hematology Research, Practice, and Training
The American Society of Hematology is committed to addressing and reversing historic inequities in hematology, supporting scientists and clinicians from backgrounds underrepresented in medicine, and elevating diverse voices across our patient and hea...
Read moreASH Statement in Support of Palliative Blood Transfusions in Hospice Setting
The American Society of Hematology (ASH) represents approximately 17,000 physicians, scientists, and medical trainees committed to the study and treatment of blood and blood-related diseases. As an organization of physicians and scientists who care f...
Read moreASH Statement of Principles on Continuous Certification
Beginning in 2001, the American Society of Hematology (ASH) questioned the underlying premise of maintenance of certification. The American Board of Medical Specialties (ABMS) Commission on Continuing Board Certification is taking a much-needed look...
Read moreStatement on Opioid Use in Patients with Hematologic Diseases and Disorders
The American Society of Hematology (ASH) represents approximately 17,000 physicians, scientists, and medical trainees committed to the study of blood and treatment of blood-related diseases. ASH members include clinicians who specialize in treating c...
Read more- 1
- 2